US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Onconetix Inc.

4.65

-0.2000-4.12%

Pre-market: 4.64-0.0100-0.22%07:17 EDT

Volume:63.92K

Turnover:299.86K

Market Cap:2.43M

PE:0.00

High:4.85

Open:4.83

Low:4.57

Close:4.85

Loading ...

Overview Company News Filings

BRIEF-Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel

Onconetix Inc: Expects to Demonstrate Compliance With Bid Price Listing Rule at Close of Business on June 27

THOMSON REUTERS

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

THOMSON REUTERS

Onconetix Inc. Completes 1-for-85 Reverse Stock Split to Meet Nasdaq Compliance

Onconetix Inc trading halted, news pending

Onconetix Inc. Announces 1-for-85 Reverse Stock Split to Regain Nasdaq Compliance

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

THOMSON REUTERS

Onconetix Inc. Conducted Special Meeting of Stockholders

Onconetix Inc. Reports 4217% Surge in Revenue for 2024, Yet Net Loss Widens by 57%

Onconetix Inc. Faces Potential Nasdaq Delisting; Hearing Scheduled for May 27, 2025

Onconetix receives additional delisting notice from Nasdaq

Onconetix Inc. Faces Nasdaq Delisting Threat Due to Delayed Financial Reports

Onconetix, Inc. Announces Receipt of Additional Notice From Nasdaq

THOMSON REUTERS

Onconetix receives additional notice from Nasdaq

Onconetix, Inc. Announces Receipt of Additional Notice From Nasdaq

THOMSON REUTERS

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

BRIEF-Onconetix Sets Stage For Potential Business Combination With Ocuvex Therapeutics

Onconetix, Ocuvex Therapeutics Sign Letter of Intent for Potential Merger; Shares Up Pre-Bell

MT Newswires Live

Onconetix Signs Letter of Intent for Potential Business Combination With Ocuvex Therapeutics, Inc.

THOMSON REUTERS

Onconetix Inc - Onconetix and Ocuvex Will Continue Negotiations to Enter Into a Definitive Agreement

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ONCO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONCO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCO\",,,,,undefined,":{"symbol":"ONCO","market":"US","secType":"STK","nameCN":"Onconetix Inc.","latestPrice":4.65,"timestamp":1751562000000,"preClose":4.85,"halted":0,"volume":63918,"hourTrading":{"tag":"盘前","latestPrice":4.64,"preClose":4.65,"latestTime":"07:17 EDT","volume":615,"amount":2828.7899775,"timestamp":1751887028569},"delay":0,"floatShares":461258,"shares":521863,"eps":-6055.384,"marketStatus":"Pre-Mkt","change":-0.2,"latestTime":"07-07 07:51:45 EDT","open":4.83,"high":4.85,"low":4.57,"amount":299857.7334,"amplitude":0.057732,"askPrice":4.64,"askSize":17,"bidPrice":4.44,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6055.384,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751895000000},"marketStatusCode":1,"adr":0,"listingDate":1645160400000,"exchange":"NASDAQ","adjPreClose":4.65,"preHourTrading":{"tag":"盘前","latestPrice":4.64,"preClose":4.65,"latestTime":"07:17 EDT","volume":615,"amount":2828.7899775,"timestamp":1751887028569},"postHourTrading":{"tag":"盘后","latestPrice":4.63,"preClose":4.65,"latestTime":"16:29 EDT","volume":3356,"amount":15123.545,"timestamp":1751574586898},"volumeRatio":0.721894443090161},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONCO\",,,,,undefined,":{"symbol":"ONCO","floatShares":461258,"roa":"-8.25%","roe":"-1180.06%","lyrEps":-7433.2466,"volumeRatio":0.721894443090161,"shares":521863,"dividePrice":0,"high":4.85,"amplitude":0.057732,"preClose":4.85,"low":4.57,"week52Low":3.82,"pbRate":"0.61","psRate":"1.26","week52High":1190,"institutionHeld":0,"latestPrice":4.65,"committee":0.709402,"eps":-6055.384,"divideRate":0,"volume":63918,"delay":0,"ttmEps":-6055.384,"open":4.83,"prevYearClose":53.55,"prevWeekClose":4.65,"prevMonthClose":4.77,"prevQuarterClose":4.77,"fiveDayClose":4.65,"twentyDayClose":6.2475,"sixtyDayClose":6.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONCO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543314677","title":"BRIEF-Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2543314677","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543314677?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:32","pubTimestamp":1750077161,"startTime":"0","endTime":"0","summary":"BRIEF-Onconetix, Inc. Announces Positive Decision By Nasdaq Hearings PanelJune 16 (Reuters) - Onconetix Inc ONCO.O:ONCONETIX, INC. ANNOUNCES POSITIVE DECISION BY NASDAQ HEARINGS PANELONCONETIX INC: EX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SJ09L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2543867222","title":"Onconetix Inc: Expects to Demonstrate Compliance With Bid Price Listing Rule at Close of Business on June 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2543867222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543867222?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:22","pubTimestamp":1750076533,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SJ09L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2543722496","title":"Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2543722496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543722496?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:22","pubTimestamp":1750076533,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SJ09L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2543722266","title":"Onconetix Inc. Completes 1-for-85 Reverse Stock Split to Meet Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2543722266","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543722266?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:22","pubTimestamp":1750076529,"startTime":"0","endTime":"0","summary":"Onconetix Inc.  has announced a 1-for-85 reverse stock split of its outstanding shares of common stock, effective at 12:01 a.m. Eastern Time on June 13, 2025. This move is part of the company's efforts to comply with Nasdaq's listing requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire  on June 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDLQNPPz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4585","BK4588","IE00B64PRP62.GBP","BK4139","IE00BGHQF748.EUR","LU2210150020.SGD","LU2095319765.USD","ONCO","IE00BKPKM429.USD","IE00B3QW5Z07.USD","NDAQ","BK4112"],"gpt_icon":0},{"id":"2543525457","title":"Onconetix Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2543525457","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543525457?lang=en_us&edition=fundamental","pubTime":"2025-06-13 07:50","pubTimestamp":1749772223,"startTime":"0","endTime":"0","summary":"19:50 EDT Onconetix (ONCO) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onconetix-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onconetix-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2542535467","title":"Onconetix Inc. Announces 1-for-85 Reverse Stock Split to Regain Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2542535467","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542535467?lang=en_us&edition=fundamental","pubTime":"2025-06-11 23:30","pubTimestamp":1749655814,"startTime":"0","endTime":"0","summary":"Onconetix Inc., a biotechnology company specializing in men's health and oncology, has announced a 1-for-85 reverse stock split effective June 13, 2025. This move, approved at the company's recent special stockholder meeting, will reduce the number of outstanding shares from approximately 44.4 million to 521,863. The company aims to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share. Onconetix will continue trading under the symbol \"ONCO\" with a new CUSIP number.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire  on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL4fMGCP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","BK4139","IE00B64PRP62.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","ONCO","LU2095319765.USD","BK4585","LU2210149790.SGD","BK4112"],"gpt_icon":0},{"id":"2542535148","title":"Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2542535148","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542535148?lang=en_us&edition=fundamental","pubTime":"2025-06-11 23:30","pubTimestamp":1749655800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nTUA74TGPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2541005935","title":"Onconetix Inc. Conducted Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2541005935","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541005935?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:13","pubTimestamp":1749154411,"startTime":"0","endTime":"0","summary":"On May 30, 2025, Onconetix Inc. held its 2025 special meeting of stockholders. During the meeting, two key proposals were voted on. The first proposal was to approve and adopt an amendment to the Amended and Restated Certificate of Incorporation to effect a reverse stock split of the company's outstanding common stock at a ratio to be determined by the Board. This proposal was approved. The second proposal was to approve the adjournment of the Special Meeting if necessary to solicit additional proxies for the Reverse Stock Split Proposal. This proposal was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL2sXnZx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2540760384","title":"Onconetix Inc. Reports 4217% Surge in Revenue for 2024, Yet Net Loss Widens by 57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760384","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760384?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:42","pubTimestamp":1748864540,"startTime":"0","endTime":"0","summary":"Onconetix Inc. has released its financial results for the fiscal year ending December 31, 2024. The company reported a significant increase in revenue, reaching $2.52 million compared to $58,465 in the previous year, marking a 4217.3% surge. Despite this revenue growth, the company experienced a wider net loss of $58.69 million, compared to a net loss of $37.41 million in 2023, representing a 56.9% increase in losses. The increase in revenue was coupled with an increase in the cost of revenue, which rose to $1.47 million from $1.19 million, a 23.9% increase. As a result, the gross profit turned positive, with a gain of $1.06 million, compared to a gross loss of $1.13 million in the previous year, showing a significant improvement of 193.6%. Operating expenses saw a decrease, with selling, general, and administrative expenses dropping by 24.0% to $11.23 million from $14.77 million. Research and development expenses also saw a substantial decline of 92.1%, down to $154,359 from $1.95 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL90l7Pz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Onconetix Inc. Reports 4217% Surge in Revenue for 2024, Yet Net Loss Widens by 57%","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCO"],"gpt_icon":0},{"id":"2537992708","title":"Onconetix Inc. Faces Potential Nasdaq Delisting; Hearing Scheduled for May 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537992708","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537992708?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:11","pubTimestamp":1747948296,"startTime":"0","endTime":"0","summary":"Onconetix Inc. announced it has received a delisting notice from Nasdaq due to its failure to file its Quarterly Report for the period ending March 31, 2025. Additionally, the company is not in compliance with the minimum bid price requirement, which could lead to its delisting. A hearing before the Nasdaq Hearings Panel is scheduled for May 27, 2025, which will determine the future of Onconetix's listing status. In the meantime, the company intends to file its pending reports promptly to regain compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDLN74Dr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2537927220","title":"Onconetix receives additional delisting notice from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927220","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927220?lang=en_us&edition=fundamental","pubTime":"2025-05-23 05:00","pubTimestamp":1747947617,"startTime":"0","endTime":"0","summary":"Onconetix (ONCO) received a staff delisting letter from Nasdaq on May 20 indicating that the company’s failure to file its Quarterly Report Q for t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onconetix-receives-additional-delisting-notice-from-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onconetix-receives-additional-delisting-notice-from-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BGHQF748.EUR",".IXIC","LU2210150020.SGD","BK4585","QID","ONCO","USAW.SI","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","NVIW.SI","NDAQ","USJW.SI","BK4588","TQQQ","NQmain","IE00B3QW5Z07.USD","SQQQ","TSYW.SI","QLD","PSQ","BK4139","BK4112","LU2095319765.USD","MNQmain"],"gpt_icon":0},{"id":"2537927623","title":"Onconetix Inc. Faces Nasdaq Delisting Threat Due to Delayed Financial Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927623","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927623?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:50","pubTimestamp":1747947009,"startTime":"0","endTime":"0","summary":"Onconetix Inc.  has announced the receipt of a delisting notice from Nasdaq due to the company's failure to file its Quarterly Report on Form 10-Q for the period ending March 31, 2025, and its Annual Report on Form 10-K for the fiscal year ending December 31, 2024. This non-compliance with Nasdaq's listing requirements has prompted a hearing scheduled for May 27, 2025, to address the issue and consider the company's request for a stay on the suspension of its securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire  on May 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL5MpyYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2095319765.USD","IE00B64PRP62.GBP","BK4139","IE00BGHQF748.EUR","ONCO","BK4588","BK4585","LU2210150020.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4112","NDAQ"],"gpt_icon":0},{"id":"2537392766","title":"Onconetix, Inc. Announces Receipt of Additional Notice From Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2537392766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537392766?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:50","pubTimestamp":1747947000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nTUA87PBCC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2532090531","title":"Onconetix receives additional notice from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2532090531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532090531?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:20","pubTimestamp":1746051621,"startTime":"0","endTime":"0","summary":"Onconetix (ONCO) announced that it received a Staff delisting letter from The Nasdaq Capital Market on April 24, 2025 indicating that the company’s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onconetix-receives-additional-notice-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onconetix-receives-additional-notice-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2210150020.SGD","USAW.SI","PSQ","QLD","TSYW.SI","BK4112","NQmain","IE00B3QW5Z07.USD","NVIW.SI","TQQQ","IE00BGHQF748.EUR","QID","NDAQ","BK4588","SQQQ","BK4139","MNQmain","USJW.SI","IE00B64PRP62.GBP","LU2095319765.USD","IE00BKPKM429.USD","ONCO","LU2210149790.SGD",".IXIC"],"gpt_icon":0},{"id":"2532979890","title":"Onconetix, Inc. Announces Receipt of Additional Notice From Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2532979890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532979890?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:13","pubTimestamp":1746051219,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA1DKJXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2532609083","title":"Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2532609083","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532609083?lang=en_us&edition=fundamental","pubTime":"2025-05-01 06:13","pubTimestamp":1746051180,"startTime":"0","endTime":"0","summary":"Cincinnati, OH, April 30, 2025  -- Onconetix, Inc.   announced that it received a Staff delisting letter from The Nasdaq Capital Market  on April 24, 2025 indicating that the Company’s failure to file its Annual Report on Form 10-K for the fiscal year ended December 30, 2024 is in violation of Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250 .This announcement is made in compliance with Nasdaq Listing Rule 5810, which requires prompt disclosure of receipt of a deficiency notification.Onconetix is a commercial stage biotechnology company focused on the research, development and commercialization of innovative solutions for men’s health and oncology. Through our acquisition of Proteomedix, we own Proclarix, an in vitro diagnostic test for prostate cancer originally developed by Proteomedix and approved for sale in the European Union  under the In Vitro Diagnostic Regulation . We also own ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalaf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/onconetix-inc-announces-receipt-additional-221300557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","USAW.SI",".IXIC","IE00BKPKM429.USD","BK4588","PSQ","BK4585","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210149790.SGD","QID","BK4139","NQmain","QLD","BK4112","USJW.SI","MNQmain","LU2095319765.USD","TSYW.SI","NVIW.SI","NDAQ","ONCO","LU2210150020.SGD","IE00B3QW5Z07.USD","TQQQ"],"gpt_icon":1},{"id":"2525890631","title":"BRIEF-Onconetix Sets Stage For Potential Business Combination With Ocuvex Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2525890631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525890631?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:25","pubTimestamp":1744118718,"startTime":"0","endTime":"0","summary":"BRIEF-Onconetix Sets Stage For Potential Business Combination With Ocuvex TherapeuticsApril 8 (Reuters) - Onconetix and Ocuvex Therapeutics:ONCONETIX SIGNS LETTER OF INTENT FOR POTENTIAL BUSINESS COMB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM0U0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ONCO"],"gpt_icon":0},{"id":"2525977538","title":"Onconetix, Ocuvex Therapeutics Sign Letter of Intent for Potential Merger; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2525977538","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525977538?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:14","pubTimestamp":1744118096,"startTime":"0","endTime":"0","summary":"Onconetix  and Ocuvex Therapeutics said Tuesday they have signed a non-binding letter of intent for a potential merger.The companies said that as part of the potential deal, Onconetix is expected to acquire Ocuvex in exchange for newly issued Onconetix shares, with Ocuvex stockholders holding about a 90% stake in Onconetix.No specific financial terms were provided. The companies said they will continue talks for a definite agreement but said there are no guarantees that a definite deal will be reached.Shares of Onconetix were 82% higher in recent Tuesday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","LENZ","ONCO"],"gpt_icon":0},{"id":"2525891279","title":"Onconetix Signs Letter of Intent for Potential Business Combination With Ocuvex Therapeutics, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891279?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM173:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONCO","BK4139"],"gpt_icon":0},{"id":"2525891750","title":"Onconetix Inc - Onconetix and Ocuvex Will Continue Negotiations to Enter Into a Definitive Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891750?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115416,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM0U0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ONCO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONCO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-13","symbol":"ONCO","defaultRemindTime":1749821400000,"type":"split","dateTimestamp":1749787200000,"forFactor":85,"toFactor":1,"ratio":85},{"market":"US","date":"2025-06-12","symbol":"ONCO","fiscalQuarterEnding":"2025/03","expectedEps":0,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1749700800000,"reportTimeType":"post","actualEps":0.25},{"market":"US","date":"2024-09-24","symbol":"ONCO","defaultRemindTime":1727184600000,"type":"split","dateTimestamp":1727150400000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2024-05-20","symbol":"ONCO","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"post","actualEps":-0.16},{"date":"2024-04-11","symbol":"ONCO","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1712865600000,"name":null,"time":"Post Market","dateTimestamp":1712808000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONCO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONCO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONCO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONCO","date":"2025-07-03","current":-0.043242,"percent":0.808333,"low":-0.968106,"twenty":-0.196291,"median":-0.084155,"eighty":-0.044358,"high":-0.008728,"avg":-0.146648,"sd":0.18504,"marketCap":2426662},"quantilePoints":[{"date":"2023-12-29","current":-0.201955,"twenty":-0.205826,"median":-0.201955,"eighty":-0.193917,"marketCap":3691085},{"date":"2024-01-05","current":-0.194459,"twenty":-0.201955,"median":-0.195264,"eighty":-0.193719,"marketCap":3554077},{"date":"2024-01-12","current":-0.190736,"twenty":-0.197125,"median":-0.193719,"eighty":-0.190736,"marketCap":3486030},{"date":"2024-01-19","current":-0.173836,"twenty":-0.19628,"median":-0.192899,"eighty":-0.180094,"marketCap":3177158},{"date":"2024-01-26","current":-0.342039,"twenty":-0.19628,"median":-0.189647,"eighty":-0.1728,"marketCap":6251352},{"date":"2024-02-02","current":-0.174037,"twenty":-0.202407,"median":-0.192246,"eighty":-0.173635,"marketCap":3180835},{"date":"2024-02-09","current":-0.164782,"twenty":-0.198091,"median":-0.186679,"eighty":-0.170436,"marketCap":3011681},{"date":"2024-02-16","current":-0.205696,"twenty":-0.198091,"median":-0.184801,"eighty":-0.168042,"marketCap":3759458},{"date":"2024-02-23","current":-0.206429,"twenty":-0.205989,"median":-0.188558,"eighty":-0.169852,"marketCap":3772853},{"date":"2024-03-01","current":-0.208872,"twenty":-0.20842,"median":-0.192572,"eighty":-0.172015,"marketCap":3817502},{"date":"2024-03-08","current":-0.22182,"twenty":-0.213025,"median":-0.193719,"eighty":-0.17277,"marketCap":4054143},{"date":"2024-03-15","current":-0.201665,"twenty":-0.217422,"median":-0.196597,"eighty":-0.172951,"marketCap":3685787},{"date":"2024-03-22","current":-0.203986,"twenty":-0.21515,"median":-0.197125,"eighty":-0.173514,"marketCap":3728204},{"date":"2024-03-28","current":-0.2002,"twenty":-0.212952,"median":-0.198734,"eighty":-0.173916,"marketCap":3658998},{"date":"2024-04-05","current":-0.204475,"twenty":-0.211193,"median":-0.198734,"eighty":-0.174238,"marketCap":3737134},{"date":"2024-04-12","current":-0.093154,"twenty":-0.209947,"median":-0.197125,"eighty":-0.174238,"marketCap":3484866},{"date":"2024-04-19","current":-0.079022,"twenty":-0.209385,"median":-0.195935,"eighty":-0.172739,"marketCap":2956187},{"date":"2024-04-26","current":-0.07186,"twenty":-0.2087,"median":-0.194214,"eighty":-0.166713,"marketCap":2688255},{"date":"2024-05-03","current":-0.067443,"twenty":-0.208428,"median":-0.193586,"eighty":-0.15949,"marketCap":2523030},{"date":"2024-05-10","current":-0.066787,"twenty":-0.208202,"median":-0.192246,"eighty":-0.083892,"marketCap":2498469},{"date":"2024-05-17","current":-0.084155,"twenty":-0.207504,"median":-0.190061,"eighty":-0.075083,"marketCap":3148205},{"date":"2024-05-24","current":-0.069112,"twenty":-0.206722,"median":-0.188558,"eighty":-0.074211,"marketCap":3157136},{"date":"2024-05-31","current":-0.116278,"twenty":-0.206282,"median":-0.18621,"eighty":-0.07464,"marketCap":5311760},{"date":"2024-06-07","current":-0.08705,"twenty":-0.205452,"median":-0.178162,"eighty":-0.074985,"marketCap":3976563},{"date":"2024-06-14","current":-0.070578,"twenty":-0.204475,"median":-0.174289,"eighty":-0.074605,"marketCap":3224120},{"date":"2024-06-21","current":-0.075759,"twenty":-0.204269,"median":-0.173433,"eighty":-0.074474,"marketCap":3460793},{"date":"2024-06-28","current":-0.100148,"twenty":-0.204171,"median":-0.17293,"eighty":-0.07408,"marketCap":4574945},{"date":"2024-07-05","current":-0.078056,"twenty":-0.203986,"median":-0.171849,"eighty":-0.074605,"marketCap":3565733},{"date":"2024-07-12","current":-0.070578,"twenty":-0.203986,"median":-0.1678,"eighty":-0.07371,"marketCap":3224120},{"date":"2024-07-15","current":-0.074977,"twenty":-0.203742,"median":-0.166895,"eighty":-0.073758,"marketCap":3425069},{"date":"2024-08-02","current":-0.097024,"twenty":-0.203498,"median":-0.165989,"eighty":-0.073806,"marketCap":4432207},{"date":"2024-08-09","current":-0.087113,"twenty":-0.202765,"median":-0.164732,"eighty":-0.074211,"marketCap":3979455},{"date":"2024-08-16","current":-0.091286,"twenty":-0.202441,"median":-0.148887,"eighty":-0.074675,"marketCap":4170088},{"date":"2024-08-23","current":-0.103936,"twenty":-0.201937,"median":-0.114182,"eighty":-0.074801,"marketCap":4747943},{"date":"2024-08-30","current":-0.075134,"twenty":-0.201812,"median":-0.103936,"eighty":-0.074889,"marketCap":3991369},{"date":"2024-09-06","current":-0.071275,"twenty":-0.201372,"median":-0.101719,"eighty":-0.07464,"marketCap":3786324},{"date":"2024-09-13","current":-0.074303,"twenty":-0.199931,"median":-0.100613,"eighty":-0.073472,"marketCap":3947190},{"date":"2024-09-20","current":-0.06477,"twenty":-0.198832,"median":-0.097806,"eighty":-0.072904,"marketCap":3440758},{"date":"2024-09-27","current":-0.047041,"twenty":-0.198734,"median":-0.097089,"eighty":-0.072123,"marketCap":2498940},{"date":"2024-10-04","current":-0.702586,"twenty":-0.201861,"median":-0.097806,"eighty":-0.072322,"marketCap":37323522},{"date":"2024-10-11","current":-0.804153,"twenty":-0.203742,"median":-0.100613,"eighty":-0.072761,"marketCap":42719049},{"date":"2024-10-18","current":-0.880664,"twenty":-0.205452,"median":-0.101719,"eighty":-0.072874,"marketCap":46783580},{"date":"2024-10-25","current":-0.626146,"twenty":-0.208304,"median":-0.106675,"eighty":-0.072904,"marketCap":33262793},{"date":"2024-10-31","current":-0.46218,"twenty":-0.209727,"median":-0.114182,"eighty":-0.073022,"marketCap":24552412},{"date":"2024-11-08","current":-0.379425,"twenty":-0.217422,"median":-0.148887,"eighty":-0.073022,"marketCap":20156203},{"date":"2024-11-15","current":-0.254511,"twenty":-0.219865,"median":-0.164732,"eighty":-0.073315,"marketCap":13520416},{"date":"2024-11-22","current":-0.17644,"twenty":-0.219499,"median":-0.165989,"eighty":-0.073412,"marketCap":9373049},{"date":"2024-11-29","current":-0.107738,"twenty":-0.218815,"median":-0.165889,"eighty":-0.07365,"marketCap":5723366},{"date":"2024-12-06","current":-0.098369,"twenty":-0.217666,"median":-0.160355,"eighty":-0.073901,"marketCap":5225682},{"date":"2024-12-13","current":-0.075065,"twenty":-0.217422,"median":-0.144138,"eighty":-0.074232,"marketCap":3873640},{"date":"2024-12-20","current":-0.057866,"twenty":-0.214393,"median":-0.114182,"eighty":-0.073393,"marketCap":2986104},{"date":"2024-12-27","current":-0.056259,"twenty":-0.21261,"median":-0.110145,"eighty":-0.072963,"marketCap":2903156},{"date":"2025-01-03","current":-0.104658,"twenty":-0.211193,"median":-0.107738,"eighty":-0.072874,"marketCap":5400701},{"date":"2025-01-10","current":-0.087844,"twenty":-0.210021,"median":-0.107738,"eighty":-0.072904,"marketCap":4533072},{"date":"2025-01-17","current":-0.082411,"twenty":-0.209556,"median":-0.104481,"eighty":-0.073022,"marketCap":4252710},{"date":"2025-01-24","current":-0.077155,"twenty":-0.208872,"median":-0.103034,"eighty":-0.073022,"marketCap":3981472},{"date":"2025-01-31","current":-0.090802,"twenty":-0.208442,"median":-0.10198,"eighty":-0.073315,"marketCap":4685695},{"date":"2025-02-07","current":-0.105075,"twenty":-0.208406,"median":-0.10224,"eighty":-0.073412,"marketCap":5422267},{"date":"2025-02-14","current":-0.087185,"twenty":-0.207895,"median":-0.101296,"eighty":-0.07371,"marketCap":4499063},{"date":"2025-02-21","current":-0.067511,"twenty":-0.207113,"median":-0.100929,"eighty":-0.073393,"marketCap":3483788},{"date":"2025-02-28","current":-0.049315,"twenty":-0.206527,"median":-0.100148,"eighty":-0.072875,"marketCap":2544824},{"date":"2025-03-07","current":-0.036777,"twenty":-0.205843,"median":-0.098528,"eighty":-0.072195,"marketCap":1897835},{"date":"2025-03-14","current":-0.020864,"twenty":-0.204719,"median":-0.098369,"eighty":-0.071225,"marketCap":1076656},{"date":"2025-03-21","current":-0.020944,"twenty":-0.204269,"median":-0.097978,"eighty":-0.070572,"marketCap":1080803},{"date":"2025-03-28","current":-0.017312,"twenty":-0.204032,"median":-0.097741,"eighty":-0.069818,"marketCap":893342},{"date":"2025-04-04","current":-0.0122,"twenty":-0.203986,"median":-0.097063,"eighty":-0.069089,"marketCap":629570},{"date":"2025-04-11","current":-0.009323,"twenty":-0.203009,"median":-0.096444,"eighty":-0.068134,"marketCap":481094},{"date":"2025-04-17","current":-0.00958,"twenty":-0.202765,"median":-0.095559,"eighty":-0.067511,"marketCap":494366},{"date":"2025-04-25","current":-0.011091,"twenty":-0.202279,"median":-0.093131,"eighty":-0.066512,"marketCap":572336},{"date":"2025-05-02","current":-0.012554,"twenty":-0.201928,"median":-0.092586,"eighty":-0.065058,"marketCap":647818},{"date":"2025-05-09","current":-0.011702,"twenty":-0.201763,"median":-0.090913,"eighty":-0.063884,"marketCap":603856},{"date":"2025-05-16","current":-0.011991,"twenty":-0.200786,"median":-0.088907,"eighty":-0.05784,"marketCap":618787},{"date":"2025-05-23","current":-0.023761,"twenty":-0.199394,"median":-0.088096,"eighty":-0.054651,"marketCap":1226160},{"date":"2025-05-30","current":-0.068768,"twenty":-0.198807,"median":-0.087659,"eighty":-0.054651,"marketCap":3548673},{"date":"2025-06-06","current":-0.052528,"twenty":-0.198734,"median":-0.087113,"eighty":-0.054651,"marketCap":3082910},{"date":"2025-06-13","current":-0.058572,"twenty":-0.19856,"median":-0.086807,"eighty":-0.054651,"marketCap":3286955},{"date":"2025-06-20","current":-0.037197,"twenty":-0.198065,"median":-0.086363,"eighty":-0.052105,"marketCap":2087452},{"date":"2025-06-27","current":-0.043242,"twenty":-0.196958,"median":-0.084244,"eighty":-0.047082,"marketCap":2426662},{"date":"2025-07-03","current":-0.043242,"twenty":-0.196291,"median":-0.084155,"eighty":-0.044358,"marketCap":2426662}],"updateTime":1751861533007}}}